Profile
QTI ABT BSX-PA SYK MDT BSX
Company Name QT Imaging Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $135.67M $192.90B $175.45B $137.02B $131.98B $113.11B
Employees 0.01K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Raluca Dinu Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
QTI ABT BSX-PA SYK MDT BSX
Quant Rating Score 2 2 3 3 1
Quant Rating Sell Sell Neutral Neutral Strong Sell
Trading
QTI ABT BSX-PA SYK MDT BSX
Last Close $0.3951 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $0.57 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $0.35 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High -30.68 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 12.89 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
QTI ABT BSX-PA SYK MDT BSX
1 Month Return 0 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 0 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 0 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return 0 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return -19.04 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return -30.07 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
QTI ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.17 % - 0.95 % 2.75 % -
Dividend Paid and Capex Coverage Ration (TTM) -114.24 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
QTI ABT BSX-PA SYK MDT BSX
Asset Growth 25913.02 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth - 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth - 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year 1426011.79 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year 1426011.79 % 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year 1426011.79 % 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth 100 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth -276000.26 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share -279215.15 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share -279215.15 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share -279215.15 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth -247018.41 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) -515997.75 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG -396615.5 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG -396615.5 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG -396615.5 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth -31.48 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth -31.48 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share -42730.02 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share -346597.45 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share -346597.45 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share -346597.45 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth 322472.06 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth -520514.53 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
QTI ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 54.1 % 55.51 % 65.05 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -116859.9 % 7.75 % 6.53 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM 592.17 % 13.18 % 12.42 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM 1956690.96 % 11.56 % 8.97 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 157.38 % 77.06 % 85.26 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 73.95 % 105.19 % 97.5 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -249.13 % 18.16 % 17.33 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -100768.82 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 1505.94 4.26 6.84 6.22 5.44 7.1
Payables Turnover TTM 1110.52 4.78 6.75 - 5.08 6.21
Inventory Turnover TTM 427.73 2.94 2.32 1.72 2.13 2.13
Fixed Asset Turnover TTM 615274.89 % 385.33 % 451.15 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 40304.29 % 52.66 % 45.31 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -104.46 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -105.38 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 1.81 % 442.64 % 86.05 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -205.32 % 20.57 % 23.91 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.88 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -100768.82 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -0.01 27.89 35.99 31.99 25.35 29.96
Price To Operating Cash Flows Ratio TTM -0.05 21.23 29.35 27.17 18.54 24.45
Price Cash Flow Ratio TTM -0.05 21.23 29.35 27.17 18.54 24.45
Income Statement (TTM)
QTI ABT BSX-PA SYK MDT BSX
Revenue $4.88B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $2.64B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 54.11% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-12.18B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-14.17B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -0.71 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
QTI ABT BSX-PA SYK MDT BSX
Long Term Debt $4.51B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $15.62B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $-9.54B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $9.91B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $6.09B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
QTI ABT BSX-PA SYK MDT BSX
Net Income $-8.98B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $1.51B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-10.03B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0.09B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 110.83
ADGM Adagio Medical Holdings, Inc. 0.99
AEMD Aethlon Medical, Inc. 2.23
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.65
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 187.6
ALUR Allurion Technologies Inc. 1.1
AMIX Autonomix Medical, Inc. Common Stock 0.3984
ANIK Anika Therapeutics, Inc. 10.46
AORT Artivion, Inc. 39.59
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.88
ARAY Accuray Incorporated 0.62
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.82
AVNS Avanos Medical, Inc. 14.59
AVR Anteris Technologies Global Corp. Common Stock 5.49
AXDX Accelerate Diagnostics, Inc. 0.034
Unlock